{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05324943",
            "orgStudyIdInfo": {
                "id": "FLT201-01"
            },
            "organization": {
                "fullName": "Freeline Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Gene Therapy Study in Patients With Gaucher Disease Type 1",
            "officialTitle": "A Phase 1, Open-label, Safety, Tolerability, and Efficacy Study of FLT201 in Adult Patients With Gaucher Disease Type 1 (GALILEO-1)",
            "acronym": "GALILEO-1",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-gene-therapy-study-in-patients-with-gaucher-disease-type"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-04-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-28",
            "studyFirstSubmitQcDate": "2022-04-08",
            "studyFirstPostDateStruct": {
                "date": "2022-04-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-14",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Freeline Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "This study is a first-in-human, open-label, safety, tolerability, and efficacy study in adult patients with Gaucher disease Type 1. The aims are to investigate the safety/tolerability and efficacy of FLT201, and to investigate the relationship of FLT201 dose to augmentation of residual glucocerebrosidase (GCase) expression (activity and concentration), and its potential to improve the clinical phenotype by reduction and prevention of cellular accumulation of GCase substrate."
        },
        "conditionsModule": {
            "conditions": [
                "Gaucher Disease, Type 1"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 18,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "FLT201",
                    "type": "EXPERIMENTAL",
                    "description": "FLT201 is an advanced therapy investigational medicinal product (ATIMP) administered as a single intravenous infusion.",
                    "interventionNames": [
                        "Genetic: FLT201"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "FLT201",
                    "description": "FLT201 is a replication-incompetent single-stranded (ss) recombinant adeno-associated virus (AAV) vector. The vector is composed of a ss DNA genome packaged in an AAV-derived protein capsid.",
                    "armGroupLabels": [
                        "FLT201"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of treatment-emergent adverse events",
                    "description": "Treatment-emergent adverse events (including dose-limiting toxicities), with AEs graded as mild/moderate/severe.",
                    "timeFrame": "Day 1 (dosing) through the final follow-up visit at Week 38"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Adult \u2265 18 years of age.\n2. Diagnosis of Gaucher disease Type 1 with deficient GCase enzyme activity \u226430% of normal in leukocytes at diagnosis.\n3. All female patients of childbearing potential must not be lactating and must have a negative serum pregnancy test at screening and confirmed negative by urine testing prior to dosing on Day 1. Female patients of childbearing potential and male patients must be willing to follow protocol guidelines for barrier protection/contraception.\n4. Able to give full informed consent for the trial.\n5. Treatment status at screening (screening period is 16 weeks):\n\nTreated with either enzyme replacement therapy (ERT) or substrate reduction therapy (SRT) and started this treatment at least 2 years prior to dosing with no change in regimen for the prior 3 months. ERT dose \u226515 U/kg and \u226460 U/kg every other week.\n\nExclusion Criteria:\n\n1. Diagnosed or suspected Type 2 or Type 3 Gaucher disease (including any patient with eye movement abnormality on clinical examination).\n2. Positive for neutralising antibodies to AAVS3 at screening.\n3. Evidence of significant and persistent liver dysfunction at Screening defined as \\>1.5 x upper limit of normal (ULN) in alanine aminotransferase (ALT), aspartate aminotransferase (AST) or total bilirubin.\n4. Evidence of any of the following at screening:\n\n   1. Hb \\<8 g/dL.\n   2. Platelets \\<45,000/mm3.\n   3. Pulmonary hypertension.\n   4. New osteonecrosis within 12 months of screening.\n   5. Fragility fracture or bone crisis within 12 months of screening.\n5. Hepatitis B surface antigen (HBsAg) positive at screening.\n6. Hepatitis C antibody (Hep C Ab) positive and hepatitis C RNA polymerase chain reaction (PCR) (as follow-up test if Hep C Ab-positive)-positive at screening.\n7. Cytomegalovirus (CMV) immunoglobulin G (IgG) and CMV DNA PCR-positive at screening.\n8. Human immunodeficiency virus (HIV)-1 or -2 antibody positive at screening.\n9. Patient has received live attenuated vaccination within 12 weeks prior to screening or intends to receive such vaccination during the study.\n10. History of clinically-advanced liver disease e.g. cirrhosis, portal hypertension.\n11. History of bone marrow transplant.\n12. History of splenectomy (partial or total).\n13. History of splenic infarct within 12 months of screening.\n14. History of receiving any gene transfer medicinal product.\n15. History of receiving any investigational therapy for Gaucher disease within 60 days of screening.\n16. Participation in any other clinical study of an investigational medicinal product (IMP), and/or receiving any other IMP during the study.\n17. History of idiopathic thrombocytopaenic purpura, thrombotic thrombocytopaenic purpura, thrombocytopaenia, anaemia, hepatomegaly, splenomegaly, and/or osteoporosis, unrelated to Gaucher disease.\n18. History of, or active neoplastic disease within 5 years of screening (except for basal or squamous cell carcinoma of the skin or carcinoma in situ which has been definitively treated).\n19. Subjects with uncontrolled cardiac failure, unstable angina, myocardial infarction, pulmonary hypertension or cardiac presentations including cardiac instability deemed significant by the investigator in the past 6 months\n20. History of acute myocarditis or presence of acute myocarditis during screening.\n21. History of substance abuse, including alcohol abuse or alcohol dependence.\n22. Known or suspected intolerance, hypersensitivity or contraindication to the investigational medicinal product (IMP) and non-investigational medicinal products (NIMPs) or their excipients.\n23. History of anaphylaxis or infusion related reactions to ERT.\n24. Contraindication(s) to MRI. (e.g. ferromagnetic metallic implants, some types of pacing and defibrillator devices, nerve stimulators).\n25. Any clinical condition (medical or psychiatric) that, in the opinion of the investigator, could jeopardise safety or compromise ability of the patient to participate in this study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Operations",
                    "role": "CONTACT",
                    "phone": "+44 1438 906870",
                    "email": "contact@freeline.life"
                }
            ],
            "locations": [
                {
                    "facility": "Kaiser Permanente",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90027",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Divya Vats",
                            "role": "CONTACT",
                            "phone": "323-361-5704",
                            "email": "DIVYA.VATS@kp.org"
                        },
                        {
                            "name": "Divya Vats",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "New York Presbyterian/Columbia University Irving Medical Center (NYPH/CUMC)",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gustavo Maegawa",
                            "role": "CONTACT",
                            "phone": "212-305-6731",
                            "email": "lsdprogram@cumc.columbia.edu"
                        },
                        {
                            "name": "Gustavo Maegawa",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Lysosomal Rare Disorders Research and Treatment Center",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22030-6066",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lauren Noll",
                            "role": "CONTACT",
                            "phone": "703-261-6220",
                            "email": "lnoll@ldrtc.org"
                        },
                        {
                            "name": "Ozlem Goker-Alpan",
                            "role": "CONTACT",
                            "phone": "(703) 2616220",
                            "email": "ogoker-alpan@ldrtc.org"
                        },
                        {
                            "name": "Ozlem Goker-Alpan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Hospital de Clinicas de Porto Alegre (HCPA)",
                    "status": "RECRUITING",
                    "city": "Porto Alegre",
                    "country": "Brazil",
                    "contacts": [
                        {
                            "name": "Ida Schwartz",
                            "role": "CONTACT",
                            "phone": "+55 51 999017418",
                            "email": "idadschwartz@gmail.com"
                        },
                        {
                            "name": "Ida Vanessa Schwartz",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -30.03306,
                        "lon": -51.23
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Hamburg Eppendorf",
                    "status": "RECRUITING",
                    "city": "Hamburg",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Nicole Muschol",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.57532,
                        "lon": 10.01534
                    }
                },
                {
                    "facility": "SphinCS",
                    "status": "RECRUITING",
                    "city": "H\u00f6chheim",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Eugen Mengel",
                            "role": "CONTACT",
                            "phone": "0049-6146-904820",
                            "email": "info@sphincs.de"
                        },
                        {
                            "name": "Eugen Mengel",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.36667,
                        "lon": 10.45
                    }
                },
                {
                    "facility": "Shaare Zedek Medical Center",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Ari Zimran",
                            "role": "CONTACT",
                            "phone": "+972-2-6555143",
                            "email": "azimran@gmail.com"
                        },
                        {
                            "name": "Shoshana Revel-Vilk",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Rabin Medical Center - PPDS",
                    "status": "RECRUITING",
                    "city": "Petah Tikva",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Noa Lev-El Halabi",
                            "role": "CONTACT",
                            "phone": "+972-3-9377522",
                            "email": "noale1@clalit.org.il"
                        },
                        {
                            "name": "Noa Ruhrman Shahar",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08707,
                        "lon": 34.88747
                    }
                },
                {
                    "facility": "Tel Aviv Sourasky Medical Center",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Dorin Trigubov",
                            "role": "CONTACT",
                            "phone": "+972-3-6974905",
                            "email": "dorint@tlvmc.gov.il"
                        },
                        {
                            "name": "Hagit Baris-Feldman",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Instituto Privado de Hematologia e Investigaciones Clinicas",
                    "status": "COMPLETED",
                    "city": "Asunci\u00f3n",
                    "country": "Paraguay",
                    "geoPoint": {
                        "lat": -25.30066,
                        "lon": -57.63591
                    }
                },
                {
                    "facility": "Hospital Universitario de Bellvitge",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Xavier Solanich Moreno",
                            "role": "CONTACT",
                            "phone": "932 60 75 00",
                            "phoneExt": "2324",
                            "email": "xsolanich@bellvitgehospital.cat"
                        },
                        {
                            "name": "Xavier Solanich Moreno",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitario Vall d'Hebr\u00f3n",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Maria Camprodon",
                            "role": "CONTACT",
                            "phone": "(0034)677072506",
                            "email": "maria.camprodon@vallhebron.cat"
                        },
                        {
                            "name": "Maria Camprodon",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitario Ramon y Cajal",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Esther Agea",
                            "role": "CONTACT",
                            "phone": "91 3368967",
                            "email": "ec.hemato.esther.agea@gmail.com"
                        },
                        {
                            "name": "Jesus Villarrubia",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Quironsalud Zaragoza",
                    "status": "RECRUITING",
                    "city": "Zaragoza",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Pilar Giraldo",
                            "role": "CONTACT",
                            "phone": "+34670285339",
                            "email": "giraldocastellano@gmail.com"
                        },
                        {
                            "name": "Pilar Giraldo",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.65606,
                        "lon": -0.87734
                    }
                },
                {
                    "facility": "Royal Free Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Derralynn Hughes",
                            "role": "CONTACT",
                            "phone": "02077940500",
                            "email": "derralynnhughes@nhs.net"
                        },
                        {
                            "name": "Derralynn Hughes",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Salford Royal Hospital",
                    "status": "RECRUITING",
                    "city": "Salford",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Marie Meehan",
                            "role": "CONTACT",
                            "phone": "07799797743",
                            "email": "Marie.meehan@nca.nhs.uk"
                        },
                        {
                            "name": "Reena Sharma",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.48771,
                        "lon": -2.29042
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Argentina",
                "Italy",
                "Tunisia"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005776",
                    "term": "Gaucher Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000013106",
                    "term": "Sphingolipidoses"
                },
                {
                    "id": "D000020140",
                    "term": "Lysosomal Storage Diseases, Nervous System"
                },
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000008064",
                    "term": "Lipidoses"
                },
                {
                    "id": "D000008052",
                    "term": "Lipid Metabolism, Inborn Errors"
                },
                {
                    "id": "D000016464",
                    "term": "Lysosomal Storage Diseases"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000052439",
                    "term": "Lipid Metabolism Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8891",
                    "name": "Gaucher Disease",
                    "asFound": "Gaucher Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15904",
                    "name": "Sphingolipidoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M18871",
                    "name": "Lysosomal Storage Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M11064",
                    "name": "Lipidoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M11054",
                    "name": "Lipid Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27029",
                    "name": "Lipid Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2449",
                    "name": "Gaucher Disease",
                    "asFound": "Gaucher Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2452",
                    "name": "Gaucher Disease Type 1",
                    "asFound": "Gaucher Disease Type 1",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5335",
                    "name": "Sphingolipidosis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}